COVID-19 in patients with rare diseases of the respiratory system

DG Sante (European commission), T.O. F. Wagner (Frankfurt/Main, Germany), I. Fajac (Paris, France), M. Kreuter (Heidelberg, Germany), G. Verleden (Leuven, Belgium), M. Humbert (Paris, France), Heymut Omran (Münster, Germany)

Source: ERS webinar 2020: COVID-19 in patients with rare diseases of the respiratory system
Number: 0
Disease area: -

WebcastPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
DG Sante (European commission), T.O. F. Wagner (Frankfurt/Main, Germany), I. Fajac (Paris, France), M. Kreuter (Heidelberg, Germany), G. Verleden (Leuven, Belgium), M. Humbert (Paris, France), Heymut Omran (Münster, Germany). COVID-19 in patients with rare diseases of the respiratory system. ERS webinar 2020: COVID-19 in patients with rare diseases of the respiratory system

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary diseases in primary immunodeficiency syndromes
Source: Respipedia Article
Year: 2017

Drug-induced ILD
Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Year: 2007


Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011


COVID-19: Current Challenges in ILD
Source: ERS webinar 2020: COVID-19: Current Challenges in ILD
Year: 2020


Complex chronic comorbidities of COPD
Source: Eur Respir J 2008; 31: 204-212
Year: 2008



Immundefects, rare pulmonary infections and rare lung diseases
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020


Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011



Hughes-Stovin syndrome: A case report
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015


Small airways diseases, excluding asthma and COPD: an overview
Source: Eur Respir Rev 2013; 22: 131-147
Year: 2013



Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005



Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001



Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
Source: Eur Respir J 2012; 39: 669-676
Year: 2012



Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Pulmonary involvement in children with rheumatic diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Drug-induced infiltrative lung disease
Source: Eur Respir J 2001; 18: 93S-100S
Year: 2001



An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013